-
Study aim
-
The aim of this study was to assess the efficiency, as clinical healing, of the application of platelet-rich plasma (PRP) gel in the extraction sockets in patients treated with bisphosphonates at risk of medication-related osteonecrosis of the jaw (MRONJ)
-
Design
-
single center, single-arm not randomized clinical trial
-
Settings and conduct
-
1) Clinical Evaluation
2) Computer Tomography (CT) evaluation if needed; oral hygiene instructions; pre-operatory medical therapy prescription; PRP preparation
3) Surgical procedure
4) Suture removal
5) Follow-up visits at 15, 30, 90, 180, 360 days
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
1) age > 18 years
2) metabolic bone disease and/or malignant tumors
3) treatment with bisphosphonates because of the underlying disease
4) required tooth extraction
Exclusion criteria:
1) signs of MRONJ in the surgical area
2) previous history of irradiation to the head and neck area
3) neoplastic involvement of the jaws
4) poor general conditions
5) pregnant or breast-feeding women
-
Intervention groups
-
The surgical protocol expected:
1)Chlorhexidine 0,2% mouthwashes 30 ml swished up to 60 seconds
2) local anesthesia achieved using 3% mepivacaine hydrochloride without adrenaline
3) elevation of a full-thickness mucoperiosteal flap
4) tooth luxation and avulsion
5) if necessary, osteoplasty
6) debridement of the post-extraction socket and irrigation with rifamycin sodium
7) application of a single dosage of autologous PRP (Plateltex ACT System ®, Biomed, Modena, IT)
8) suture.
To prepare the PRP and to induce its gelation, the materials provided by the manufacturer were used and the provided instructions followed [Mazzucco L, Balbo V, Cattana E, Borzini P. Platelet-rich plasma and platelet gel preparation using Plateltex. Vox Sang. 2008 Apr;94(3):202-8.]
-
Main outcome variables
-
Absence of signs related to MRONJ (Healing)